Skip to main content

Paula Fernández Álvarez

Institutions of which they are part

Research technician
Genetics Medicine
Vall Hebron Institut de Recerca

Paula Fernández Álvarez

Institutions of which they are part

Research technician
Genetics Medicine
Vall Hebron Institut de Recerca

Projects

Validación funcional de variantes en el genoma mitocondrial y nuclear en pacientes con patologia mitocondrial

IP: Elena García Arumí
Collaborators: Mª Jesus Melia Grimal, Clara Carnicer Cáceres, Paula Fernández Álvarez
Funding agency: Instituto de Salud Carlos III
Funding: 102850
Reference: PI19/01772
Duration: 01/01/2020 - 31/12/2023

Estudios funcionales de mutaciones del gen CFTR para establecer una terapia personalizada en pacientes con Fibrosis Quística

IP: Eduardo Fidel Tizzano
Collaborators: Paula Fernández Álvarez, SILVIA GARTNER TIZZANO
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 104213
Reference: MM/XIV/RECERCA/2017/TIZZANO
Duration: 10/10/2017 - 30/09/2021

Abordaje genético-molecular de enfermedades mitocondriales del sistema OXPHOS: identificación de factores condicionantes del fenotipo.

IP: Elena García Arumí
Collaborators: Albert Blanco Grau, Mª Jesus Melia Grimal, Paula Fernández Álvarez
Funding agency: Instituto de Salud Carlos III
Funding: 212052.5
Reference: PI15/01428
Duration: 01/01/2016 - 30/06/2019

Biomarcadores diagnósticos y pronósticos de recidiva de glomerulonefritis segmentaria y focal en trasplante de riñón

IP: Joan López Hellin
Collaborators: Anna Meseguer Navarro, Daniel Serón Micas, Paula Fernández Álvarez
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 20000
Reference: FMM-2011-08
Duration: 28/07/2011 - 27/07/2012

Related news

The results show that, in some patients with mutations in the X chromosome, the healthy gene is inactivated and the mutated gene manifests itself, which favors the onset of the disease.

On January 24, a session was held to explain what these three-dimensional models are and what advantages they have, as well as to review some of their applications in research.

The research has studied the structure and function of proteins related to this degenerative disease and their interaction with SMN2 messenger RNA (mRNA), which is key to the evolution of patients.

Related professionals

Valeria Rizzuto

Valeria Rizzuto

Predoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Emanuela Greco

Emanuela Greco

Predoctoral researcher
Read more
Jose Cabral Jamba

Jose Cabral Jamba

Administrative
IT / Information Systems
Digital Transformation and Quality Area
Read more
Sebastián  Sandoval  Moreno

Sebastián Sandoval Moreno

Predoctoral researcher
Rheumatology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.